Complete the form below to download the infographic. Cell-line development (CLD) is crucial for generating therapeutic ...

Complete the form below to view the video. Generating monoclonal cell lines is fundamental to developing biomolecules like ...

Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3‑targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas ...

A comprehensive approach is necessary for navigating the highly heterogeneous nature of leukemia across different age ...

The FDA has granted fast track designation to OPN-6602, an investigational oral dual inhibitor of EP300 and CREB-binding ...

Boehringer Ingelheim and Zai Lab launch a clinical collaboration to evaluate a dual DLL3-targeting combination therapy in small cell lung cancer (SCLC) and other neuroendocrine carcinomas (NECs). Phas ...

Voltavate has been awarded $3.55 million in grant funding from the Australian Renewable Energy Agency (ARENA) to advance a new approach to battery manufacturing and accelerate its transition from ...

Introduction In the race of innovative drug R&D, whether for antibodies, peptides, or novel binding proteins, the efficiency ...

At Interpack 2026, IMA invites you on a journey through an entire pavilion in Hall 17 transformed into a living, breathing ...

Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has ...

Oklahoma will see another severe weather threat on Wednesday, a day after some storms moved through the state.

By examining genetic clues that linger in adult cells, scientists have now gained surprising insights into the developmental ...